Imperial College London

Name

Imperial College London

Legal name

Imperial College London

Website

https://imperial.ac.uk

Company type

Public

Founded year

1907

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Higher Education and Research

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (61131)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731), Services-Engineering Services (8711)

akta.pro primary industry

Public Research Universities with Comprehensive Graduate & Professional Schools (EDAHAAAF)

akta.pro secondary industry

Public Research Universities with National Laboratories/Big Science Facilities (EDAHAAAJ)

Keywords

• Higher education
• Scientific research
• Technology transfer
• Executive education
• Clinical research

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Tuition Fees: Revenue from domestic and international undergraduate, postgraduate taught, and doctoral students. UK students pay up to £9,250 per year; international students pay higher fees.
2. Research Grants and Contracts: Funding from UK research councils (UKRI, EPSRC, BBSRC, etc.), charitable foundations (Wellcome, Gates Foundation, British Heart Foundation), industry partnerships, and international sources.
3. Commercialization and Licensing: Revenue from spinout companies, technology licensing, consultancy services, and intellectual property commercialization.
4. Executive Education: Revenue from professional development programs including the Chief Data and AI Officer Programme delivered in partnership with Emeritus.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Imperial College London is a public research-intensive university delivering undergraduate, postgraduate taught, and doctoral degree programmes in science, technology, engineering, mathematics, medicine, and business. It also produces original scientific research funded by grants and industry partnerships, commercializes intellectual property through spinout companies and licensing, and offers executive education programmes for senior professionals.

Product overview

Imperial College London operates as a research university with a portfolio of spinout companies, research centers, and educational programs rather than a unified commercial product line. Key commercializable technologies include: Advanced B-Solv's solvent-free battery manufacturing process (eliminating toxic solvents from lithium-ion battery production); AI diagnostic tools including breast cancer detection systems developed with Google and diabetes risk prediction from ECG data; the Bezos Centre for Sustainable Protein (a $30M funded research center for alternative food products); and the MiMeC digital twin research center developed with GSK and Oxford for drug discovery. The university's AI Innovation Centre partnership with Lenovo and strategic collaboration with AMD represent infrastructure investments rather than standalone products. Research technologies span quantum sensing (AION project), bioimaging, metabolic research, and wearable cardiac monitoring. Educational offerings include executive education programs such as the Chief Data and AI Officer Programme.

Differentiator

Problem solved

Functional benefit

Brands

• Imperial College Business School: The business school component of Imperial College London offering MBA, Master's, and executive education programmes
• Imperial Executive Education
• EarthScale
• Imperial Global Summer School
• Imperial College Healthcare NHS Trust

Products and services

• Undergraduate Degree Programmes Over 110 undergraduate degree courses across science, engineering, medicine, and business for prospective students (domestic and international), delivered across South Kensington, White City, and Silwood Park campuses.
• Postgraduate Taught Programmes Over 200 taught Master's-level programmes across STEMM and business disciplines for postgraduate students seeking advanced specialization.
• Postgraduate Doctoral Research Programmes Doctoral and PhD research degrees supervised by leading academics, with over 500 grants from the Bill & Melinda Gates Foundation alone evidencing the scale of funded research training.
• Chief Data and AI Officer Programme Executive education programme for senior leaders (Chief Data Officers, Chief AI Officers, CDOs, CIOs) covering AI strategy, data governance, and responsible AI transformation, delivered online over seven months in partnership with Emeritus.
• Bezos Centre for Sustainable Protein Research centre developing sustainable alternative food products through advanced biotechnologies including fermentation, cultivated meat, and AI, with the goal of addressing global food security.
• Modelling-Informed Medicine Centre (MiMeC) Joint research hub with GSK and Oxford University, backed by £11 million, that creates computer models (digital twins) of organs including lungs, liver, and kidneys to accelerate drug discovery and virtual clinical trials.
• EarthScale Climate Tech Accelerator 12-month UK-wide climate tech accelerator programme supporting ventures across biomaterials, energy, carbon removal, built environment, and circular economy, co-funded by the Research England Development Fund.
• Indo-UK Life Sciences Innovation Corridor Five-year strategic partnership establishing a bi-directional exchange platform for researchers, innovators, and startups between Bengaluru and London in life sciences.
• Advanced B-Solv Solvent-Free Battery Manufacturing Technology Patented solvent-free dry electrode manufacturing process for lithium-ion batteries that eliminates toxic organic solvents, reducing production costs, energy consumption, and environmental hazards while improving battery performance, commercialized via Imperial spinout Advanced B-Solv.
• AI Breast Cancer Detection System AI system developed in collaboration with Google that analyses mammography images to detect breast cancer, achieving a 24% higher cancer detection rate than traditional screening in a 175,000-women NHS study.
• AI-ECG Risk Estimation for Diabetes Mellitus AI-powered tool developed at Imperial that predicts future diabetes risk from ECG heart tracings with approximately 70% accuracy, enabling earlier intervention before irreversible complications occur.
• AION Quantum Sensor Prototype quantum sensor developed as part of the AION collaboration that uses differential noise-cancellation between two atom interferometers to detect gravitational waves and dark matter signatures.
• GLP-1 Stimulating Fibre Supplement Fibre supplement developed from Imperial research that stimulates release of the hunger-reducing hormone GLP-1, approved by EFSA for use in food products and demonstrated in trials to prevent weight gain and improve body composition.
• Imperial Global Summer School

Quantifiable outcome

• 24% higher cancer detection rate using AI vs traditional screening
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core and flagship.

• BOLD Lab (Oxford-led)coreStrategic or Co-development Partner · 29 June 2026UKRI-funded AI research lab (£60 million total) pioneering AI systems capable of learning without vast centralized computing power. Imperial is a partner alongside Oxford, UCL, Cambridge, and Edinburgh.
• Stanford UniversitycoreStrategic or Co-development Partner · 25 June 2026Research collaboration with Stanford on intranasal vaccine platform, part of $18 million ARIA award, advancing preclinical studies toward Phase 1 and 2 human clinical trials.
• AMDflagshipStrategic or Co-development Partner · 8 June 2026Strategic collaboration on AI-enabled scientific discovery, sovereign AI infrastructure, and next-generation high-performance computing systems. AMD committed up to £2 billion investment over five years, supporting computational research across engineering, materials discovery, climate modeling, neuroscience, and genomics.
• CNRS (France)coreStrategic or Co-development Partner · 29 May 2026Metabolism research collaboration with France's National Center for Scientific Research targeting heart disease, cancer, and neurodegenerative disorders, as part of UK-France Strategic Biomedical Alliance.
• LenovocoreStrategic or Co-development Partner · 24 April 2026Partnership to establish AI Innovation Centre at Imperial's White City Deep Tech Campus, focused on real-world deployment of foundation models, agentic AI, and intelligent systems. Creates highly skilled STEM roles as part of Lenovo's expanded global R&D footprint.
• Digital RealtycoreOthers · 24 April 2026Deployed liquid-cooled HPC cluster at Digital Realty's data center in Woking, Surrey - Imperial's first direct liquid-cooled installation as part of ICICLE initiative for HPC and AI capabilities.
• C-CAMP (Centre for Cellular and Molecular Platforms)coreStrategic or Co-development Partner · 23 April 2026Five-year strategic partnership to establish Indo-UK Life Sciences Innovation Corridor, creating bi-directional exchange platform for researchers, innovators, and startups between Bengaluru and London.
• Thomson ReuterscoreStrategic or Co-development Partner · 21 March 2026Five-year partnership to establish Frontier AI Research Lab targeting highest accuracy levels required for professional use in legal and financial applications.
• GSKflagshipStrategic or Co-development Partner · 13 March 2026GSK, Imperial, and Oxford founded Modelling-Informed Medicine Centre (MiMeC) with £11 million funding to create digital twins of organs (lungs, liver, kidneys) for drug discovery and virtual clinical trials.
• GoogleflagshipStrategic or Co-development Partner · 10 March 2026Collaboration on AI breast cancer detection research. Landmark NHS study involving 175,000 women showed AI matched or exceeded human radiologists, achieving 24% higher cancer detection rate.
• Great British Railways / MoniRail ConsortiumcoreStrategic or Co-development Partner · 3 March 2026Consortium development of Railway Quantum Inertial Navigation System (RQINS) for UK's national rail network - first quantum navigation system on a mainline train.
• Qatar Environment and Energy Research Institute (HBKU)coreStrategic or Co-development Partner · 9 February 2026Two-year strategic partnership on environmental health research in arid urban environments, focusing on air pollution exposure, oxidative potential of dust, and microplastics in hot, dry climates.

Scale indicators14 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• University of Cambridge: Co-partner in the BOLD Lab UKRI AI consortium and direct UK peer for STEM research excellence, spinout formation, and Nobel-laureate density. Competes for the same student and faculty talent pool.
• University College London (UCL): London-based public research university with similar STEM depth, comparable scale (~40,000+ students, 17,000+ staff), and direct overlap in medical, engineering, and AI research. UCL is the closest direct competitor in the UK and London student/research market.
• King's College London: London research university collaborating with Imperial on the AION quantum sensing project. Strong overlap in biomedical, AI, and life sciences research; similar central-London operating environment and NHS Trust partnership model.
• University of Oxford: UK peer in the 'Oxbridge' tier and formal co-collaborator via the MiMeC digital twin centre with GSK and the BOLD Lab AI consortium. Closest domestic competitor for top students, Nobel-grade talent, and large research grants.
• ETH Zurich: European STEM-focused public research university with a comparable balance of science, engineering, and applied research. Strong peer for benchmarking spinout output and continental European research positioning.

Broad incumbents

• Massachusetts Institute of Technology (MIT): Global benchmark for STEM-intensive research universities and a consistent occupant of the QS top-5 alongside Imperial. Comparable research intensity, industry partnership model, and spinout culture (e.g., Lincoln Laboratory analog).
• Stanford University: Direct research collaborator on the intranasal vaccine platform and globally recognized for its Silicon Valley commercialization model, which Imperial's White City Deep Tech Campus explicitly mirrors.
• California Institute of Technology (Caltech): Small-but-elite STEM research institution with high Nobel density, comparable to Imperial's concentration of Fields Medal and Nobel-affiliated researchers. Peer for fundamental science and quantum/physics research depth.

Emerging players

• Tsinghua University: Asia's leading STEM research university and the most direct emerging peer in AI, biotech, and engineering. Increasingly competitive for top international students and large industry-funded research programs.

Regional players

• Nanyang Technological University (NTU Singapore): Singapore-based STEM-intensive research university operating in the same city as Imperial's Singapore Global Hub. Comparable strengths in engineering, materials, and AI; serves as a regional talent and partnership node rather than a direct London competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/imperialcollege
• YouTubeyoutube.com/user/imperialcollegevideo
• Facebookfacebook.com/imperialcollegelondon
• LinkedInlinkedin.com/company/5106
• Instagraminstagram.com/imperialcollege
• TikToktiktok.com/@imperialcollege

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries4 records

Funding overview

Funding rounds8 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imperial College London